The two-year fundraising plan every healthcare founder should write

Why two years

A healthcare company at seed today will likely raise a Series A within eighteen months and a Series B within another eighteen. That two-year window contains most of the milestones investors will diligence.

Working backwards

Start with the Series B narrative you want to tell. Identify the specific milestones — commercial, clinical, regulatory — that make that narrative credible. Then design the Series A around funding those milestones.

The milestone doc

Write down the milestones, the person accountable for each, and the review cadence. Share with your board. Revisit quarterly.

When the plan breaks

When reality diverges — and it will — the plan is what lets you make an informed pivot instead of a panicked one.

The trap of single-round thinking

Founders who plan only to their next raise tend to make milestone decisions that look reasonable in isolation but create an awkward narrative gap for the round after that, such as hitting a revenue number that satisfies a Series A but does not yet demonstrate the retention curve a Series B investor will want to see.

Working two rounds ahead forces a founder to ask not just what number gets the next check, but what story that number is setting up for the round after, which changes which milestones actually deserve the company's limited resources in the interim.

Reverse-engineering the milestone sequence

The exercise works best starting from an assumed Series B narrative, roughly eighteen to twenty-four months out, and working backward to identify the two or three proof points that narrative depends on, then further back to what needs to be true at the next raise to make those proof points achievable on that timeline.

This backward planning frequently reveals that a milestone the team assumed was sufficient, such as a single flagship pilot, will not actually satisfy the growth-stage investor's need for evidence across multiple sites or payer types, prompting an earlier and more deliberate diversification of pilot partners than the team would have otherwise pursued.

Making the plan a living document

A useful milestone document lists the specific metrics, clinical proof points, and commercial signals the next two rounds will require, alongside honest current status against each, and is revisited on a fixed cadence rather than only when a raise is imminent. This keeps the whole team oriented around the same target rather than treating fundraising as an event that happens to the company periodically.

The document is most valuable when it is specific enough to be falsifiable, naming actual target numbers and dates rather than vague directional goals, so that the team can recognize early when a milestone is genuinely at risk rather than discovering it during due diligence.

When the plan needs to break

Two-year plans are useful precisely because they create a baseline against which a founder can recognize when reality has diverged enough to require a different path, whether that is a bridge, a strategic pivot, or a change in target investor profile. The plan's value is not in being followed exactly but in making deviations visible early enough to act on.

The founders who handle this well treat a broken plan as information rather than failure, revising the milestone document candidly rather than quietly abandoning it, which keeps both the team and existing investors aligned on the new reality instead of discovering a shifted strategy only at the next board meeting.

Sharing the plan with the board

Boards generally respond well to seeing a milestone document that extends past the next raise, since it signals a founder thinking beyond the immediate fundraising event rather than managing the company round to round. Presenting the plan candidly, including where current progress is behind pace, tends to build more investor confidence than a plan that only ever shows green status.

Some founders worry that revealing a two-year plan invites board pressure to hit dates rigidly, but the more common outcome is a board that becomes a more useful partner in solving for the milestones that are genuinely at risk, precisely because the shared document makes the risk visible early rather than at the eleventh hour.